WHO ICTRP trial
Contribution of Mg supplementation and hight volume hydration to the renal…
JPRN-UMIN000013950 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000013950 |
|---|---|
| Public title | Contribution of Mg supplementation and hight volume hydration to the renal toxicity in patients with lung cancer treated by cisplatin: a historical prospective cohort study. |
| Scientific title | Contribution of Mg supplementation and hight volume hydration to the renal toxicity in patients with lung cancer treated by cisplatin: a historical prospective cohort study. - An examination of reducing the renal toxicity caused by cisplatin. |
| Primary sponsor | Department of Respiratory Medicine, Graduate school of Medicine, Osaka City University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | lung cancer patients treated with cisplatin |
| Registration date | May 13, 2014 |
| Target size | 85 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: